Prominent outside scientists who help the NIH evaluate its internal research programs are being abruptly removed ...

Shingles are more common than people think but there is help in the form of a vaccination. SHINGRIX is an FDA-approved vaccine for the prevention of shingles in adults 50 years ...

The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...

Getting the Shingrix vaccine after the age of 50 can reduce your chances of developing the painful skin condition known as ...

GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...

After multiple studies have suggested a link between its shingles vaccine and dementia prevention, GSK is taking advantage of ...

The shingles vaccine is recommended for healthy adults age 50 or older, and also for anyone age 19 years or older who has a weakened immune system (for example, if you have recently been treated for ...

Moncef Slaoui, who ran the Operation Warp Speed Covid vaccine effort, is becoming chair of Curevo, a company developing a new shingles vaccine ...

GSK partners with UK research groups to study if Shingrix shingles vaccine reduces dementia risk, analyzing NHS data from ...

The recombinant zoster vaccine is effective in preventing herpes zoster in adults aged 50 years or older with rheumatoid ...

GSK Plc is studying a large group of elderly adults in the UK to determine if its blockbuster shingles vaccine reduces the risk of dementia, potentially opening the door to an expanded label for the ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...